Imiquimod Benefits Kids Off-Label

Article

Bal Harbour, Fla. - The use of topically applied immune response modifier imiquimod (Aldara) goes beyond its FDA-approved application for the treatment of genital and perianal warts.

Related Videos
Related Content

The Weekly Roundup: September 18-22

September 22nd 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Colloidal Oatmeal Effective in Improving Atopic Dermatitis in Black Children

September 22nd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Frontline Forum Part 4: Improving Basal Cell Carcinoma Management

September 22nd 2023

Native American and Indigenous Communities Face Dermatologic Barriers to Care, Disparities, and More

September 22nd 2023

The Weekly Roundup: September 18-22

September 22nd 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Colloidal Oatmeal Effective in Improving Atopic Dermatitis in Black Children

September 22nd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Frontline Forum Part 4: Improving Basal Cell Carcinoma Management

September 22nd 2023

Native American and Indigenous Communities Face Dermatologic Barriers to Care, Disparities, and More

September 22nd 2023

The Weekly Roundup: September 18-22

September 22nd 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Colloidal Oatmeal Effective in Improving Atopic Dermatitis in Black Children

September 22nd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Frontline Forum Part 4: Improving Basal Cell Carcinoma Management

September 22nd 2023

Native American and Indigenous Communities Face Dermatologic Barriers to Care, Disparities, and More

September 22nd 2023
© 2023 MJH Life Sciences

All rights reserved.